Oriola
1.114
EUR
+0.91 %
7,691 following
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
+0.91%
+14.26%
+25.17%
+24.47%
+21.75%
+10.52%
-39.78%
-34%
-39.44%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Read moreMarket cap
202.18M EUR
Turnover
84.25K EUR
P/E (adj.) (25e)
16.93
EV/EBIT (adj.) (25e)
5.31
P/B (25e)
1.6
EV/S (25e)
0.07
Dividend yield-% (25e)
6.28 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
2.4
2025
General meeting '25
3.4
2025
Annual dividend
29.4
2025
Interim report Q1'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Oriola Oyj: Oriola's sale of Svensk dos AB to Apotekstjänst Sverige AB proceeds - sale expected to be completed in Q2 2025
Oriola Q4’24: Write-down weighed on reported earnings
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Oriola Oyj: Notice to Oriola Corporation's Annual General Meeting 2025
Oriola, Webcast, Q4'24
Oriola Oyj: Oriola Corporation's Financial Statements Release 1 January-31 December 2024
Oriola Oyj: Oriola's Board of Directors recommends that the shareholder's proposal regarding combination of share classes and directed issuance of shares without payment be accepted at the Annual General Meeting
Oriola Oyj: Oriola appoints Stig Tornell as Executive Vice President, Sales
Oriola Oyj: Oriola Corporation to publish its Financial Statements Release 2024 on 4 March 2025
Oriola Oyj: Oriola Corporation's shareholder's demand for including combination of share classes and directed issuance of shares without payment in the agenda of the Annual General Meeting
Oriola Oyj: Oriola acquires MedInfo ApS in Denmark to strengthen its Nordic footprint in medical information and patient support programmes
Oriola Oyj: Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2025 Annual General Meeting
Oriola Oyj: Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek
Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution
Oriola Oyj: The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB's appeal regarding the sale of Svensk dos AB
